The company announced Tuesday that it is experimenting with designing nanoparticles that would detect cancer and other diseases before their onset.
Andrew Conrad, head of Google (GOOG) Life Sciences division, said it would be to the body what an oil change is to a car.
"Can you imagine changing your oil when the engine is broken?" said Conrad, who made the announcement at the Wall Street Journal Digital conference.
Conrad said it's time for healthcare to become more proactive than reactive.
Google is working on a wearable device that would detect changes by monitoring nanoparticles in a person's body. That way, they could detect minor swings in tumor cells and other diseases before it becomes a problem, Conrad said.
Top 10 New Companies To Buy Right Now: Nam Tai Electronics Inc.(NTE)
Nam Tai Electronics, Inc. provides electronics manufacturing and design services to the original equipment manufacturers of telecommunication and consumer electronic products. The company?s Consumer Electronic and Communication Products segment manufactures mobile phone accessories, such as headsets containing Bluetooth wireless technology, and phone cradles, as well as snap-on portable music speaker, FM radio adaptors, and GPS adaptors; entertainment devices, including USB Web cam for interactive games, USB microphone and converter box Karaoke, and buzzer devices for quiz games; educational products consisting of digital pens, calculators, and electronic dictionaries; and optical devices comprising CMOS imaging sensor modules for notebook computers, portable media players, and recording cameras for the automotive industry. Its Telecommunication Component Assembly segment offers subassemblies and components, such as color and monochrome LCD modules for PDA phones, smart p hones, mobile phones, and telephone systems; RF modules for integration into mobile phones; DAB modules for digital radio products, including home tuners, kitchen radios, in-car receivers, CD players, clock radios, boom boxes, midi-systems, and handheld portable devices; FPC subassemblies for LCD modules and electronic devices; FPC boards for mobile phones, PDAs, office automation, and laptop computers; front and back light panels for handheld video game devices; and high-frequency cordless telephones and home feature phones. The company?s LCD Products segment manufactures LCD panels for watches and medical instruments, white goods and industrial applications, automotive parts and appliances, car audio systems, hand held products, VoIP phones, and office automation applications. It sells its products to customers in Hong Kong, North America, Europe, Japan, the People?s Republic of China, and Korea. The company was founded in 1975 and is headquartered in Shenzhen, the Peopl e?s Republic of China.
Advisors' Opinion:- [By Evan Niu, CFA]
What: Shares of Nam Tai Electronics (NYSE: NTE ) got crushed today by as much as 37% after the company reported earnings.
So what: Revenue in the first quarter more than doubled to $177.5 million, which translated into earnings per share of $0.11. Both figures handily topped consensus estimates, which were calling for $150 million in sales and $0.05 per share in profit. The real cause for concern was within Nam Tai's guidance.
- [By Rick Munarriz]
Nam Tai Electronics� (NYSE: NTE ) -- $6.78
Shares of Nam Tai took a hit three months ago after posting uninspiring quarterly results. - [By Roberto Pedone]
Another stock that's starting to move within range of triggering a big breakout trade is Nam Tai Electronics (NTE), which is an electronics manufacturing and design services provider to a select group of the world's leading OEMs of telecommunications and consumer electronic products. This stock has been destroyed by the sellers so far in 2013, with shares off sharply by 41%.
If you look at the chart for Nam Tai Electronics, you'll notice that this stock has been uptrending for the last month and change, with shares moving higher from its low of $6.05 to its recent high of $8.38 a share. During that uptrend, shares of NTE have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of NTE within range of triggering a big breakout trade.
Traders should now look for long-biased trades in NTE if it manages to break out above some key near-term overhead resistance levels at $8.38 to $8.79 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 647,483 shares. If that breakout triggers soon, then NTE will set up to re-fill some of its previous gap down zone from April that started near $11.50 a share. If this stock gets into that gap with volume, then the upside is tremendous and we could easily see NTE hit $11 to $12 a share.
Traders can look to buy NTE off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.42 a share, or below more key support at $7.22 a share. One can also buy NTE off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best Life Sciences Stocks To Buy For 2014: BlackRock Floating Rate Income Strategies Fund Inc (FRA)
BlackRock Floating Rate Income Strategies Fund, Inc. is a diversified closed-end management investment company. The Fund seeks current income and preservation of capital. It utilizes leverage through borrowings.
BlackRock Floating Rate Income Strategies Fund, Inc. invests in a diversified, leveraged portfolio consisting primarily of floating-rate debt securities and instruments. BlackRock Advisors, LLC. is the manager of the Fund. The Fund invests in floating rate loans, which are generally non-investment grade, made by banks, other financial institutions, and privately and publicly offered corporations. The portfolio of the BlackRock Floating Rate Income Strategies Fund, Inc. comprises floating rate loan interests (76%), corporate bonds (22%) and common stocks (2%) as of February 29, 2008.
Advisors' Opinion:- [By John Dowdee]
The following 10 funds satisfied all of these conditions:
BlackRock Float Rate Strategies (FRA). This CEF sells at a discount of 3%, which is low compared to an average premium of 2% over the past year. The distribution has been managed at 6.1% and a small amount (less than 10%) has been return of capital (ROC). However, this has not negatively affected net asset value (NAV) so has not been destructive. The fund holds 447 securities, with 90% in floating rate loans. FRA utilizes 27% leverage and has an expense ratio of 1.7%, including interest payments. Eaton Vance Floating Rate (EFR). This CEF sells at a 1% premium, which is low compared to an average premium of 5% over the past year. The distribution is 6.2%, none of which was ROC. The fund holds 800 securities, with 90% in floating rate loans. About 85% of the securities are from U.S. companies. EFR utilizes 35% leverage and has an expense ratio of 1.8% including interest payments. ING Prime Rate Trust (PPR). This CEF sells for a premium of 2%, which is below the average premium of 5%. It has a distribution of 6.8%, none of which was ROC. The fund has 350 holdings, virtually all in senior loans and from US companies. PPR utilizes 29% leverage and has a high expense ratio of 2.1%, including interest payments. Invesco VK Dynamic Credit Opportunities (VTA). This CEF sells for a discount of 5%, which is below the average discount of 1%. It has a distribution of 7.1%, none of which was ROC. The fund has 495 holdings, with 76% in floating rate loans. About 25% of the loans are from non-US companies. VTA utilizes a relatively low 20% leverage but still has a high expense ratio of 2.1%, including interest payments. Invesco VK Senior Income (VVR). This CEF sells for a discount of 1%, which is below the average premium of 3%. It has a distribution of 7.1%, none of which was ROC. The fund has over 500 holdings, with 89% in floating rate loans. Almost all (95%) securities are from US companies. VVR ut
Best Life Sciences Stocks To Buy For 2014: Zimmer Holdings Inc.(ZMH)
Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. The company offers orthopedic reconstructive devices that restore function lost due to disease or trauma in joints such as knees, hips, shoulders, and elbows; dental reconstructive implants, which restore function and aesthetics in patients who have lost teeth due to trauma or disease; spinal devices that are utilized by orthopedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and trauma in various regions of the spine; and trauma devices used primarily to reattach or stabilize damaged bone and tissue to support the body?s natural healing process. It also provides surgical products comprising surgical supplies and instruments designed to aid in orthopedic surgical proce dures and post-operation rehabilitation. In addition, the company offers healthcare consulting services. Its customers include orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, and healthcare dealers, as well as agents, healthcare purchasing organizations, or buying groups. The company was founded in 1927 and is headquartered in Warsaw, Indiana.
Advisors' Opinion:- [By Sean Williams]
One medical-device maker to avoid
While it's certainly far from a disaster case, I believe income seekers looking at orthopedic reconstructive-device maker Zimmer Holdings (NYSE: ZMH ) would be better served looking elsewhere. From a cash perspective, Medtronic and ResMed both carry net cash positions, while Smith & Nephew and Zimmer both lug around net debt positions. Zimmer's net debt of $450 million, though, is more than double that of Smith & Nephew and acts as an added drag when it comes to raising its dividend or making earnings-accretive acquisitions. - [By Dan Carroll]
The industry's way of the future
Emerging market trauma buys isn't a new trend. Smith & Nephew follows in the footsteps of Stryker (NYSE: SYK ) , its fellow orthopedics player that spent $764 million on purchasing China's largest trauma business, Trauson Holdings, back in January. Zimmer Holdings (NYSE: ZMH ) also took a step into China's orthopedics market, purchasing Chinese�firm Montagne back in 2010 to push its own emerging market expansion.
Best Life Sciences Stocks To Buy For 2014: Vocus Inc.(VOCS)
Vocus, Inc. provides cloud marketing software that enables businesses attract, engage, and retain customers in the United States, Europe, Asia, and Morocco. It offers a suite of software for social media marketing, search marketing, email marketing, and publicity. The company?s cloud marketing solutions include search marketing and news distribution solution that helps customers increase their online visibility and organic search engine rankings with press releases; and email marketing solution, which provides a method of keeping in touch with prospects and customers by using professional looking emails to send newsletters, special offers, and other useful content. Its cloud marketing solutions also comprise social media software solution that helps customers run social marketing campaigns, as well as monitor and analyze conversations across multiple social networks and other online Websites; and publicity solution, which offers media database, news monitoring, and analyt ics and publicity opportunities that help companies increase their media exposure, manage relationships with reporters, and monitor and analyze trends unfolding in the media. The company also provides professional services that consist of data migration, custom development, and training. Vocus, Inc. sells its products to the financial and insurance, technology, healthcare and pharmaceutical, and retail and consumer products industries, as well as government agencies, not-for-profit organizations, and educational institutions through its direct sales channels, indirect sales channels, and the Internet. Vocus, Inc. was founded in 1988 and is headquartered in Beltsville, Maryland.
Advisors' Opinion:- [By The GeoTeam]
Our recent 2013 articles on SaaS companies Selectica (SLTC), E2open (EOPN), Responsys (MKTG), Vocus (VOCS), and ExactTarget (ET) highlighted such opportunities. The average return since the inception of our coverage currently stands at around 34% (55% at their highs).
- [By Seth Jayson]
Vocus (Nasdaq: VOCS ) reported earnings on April 23. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Vocus met expectations on revenues and missed estimates on earnings per share. - [By Rich Smith]
In a separate statement, the company announced a small change in management, bringing in ex-Vocus (NASDAQ: VOCS ) Chief Operating Officer William R. Wagner to become its own COO. In an SEC filing, LogMeIn noted that it will pay Wagner $400,000 in annual base salary, plus:
Best Life Sciences Stocks To Buy For 2014: Nuveen Insured California Premium Income Municipal Fund II In (NCL)
Norwegian Cruise Line Holdings Ltd., through its subsidiaries, operates as a cruise line operator, offering cruise experiences for travelers with various itineraries in North America, the Mediterranean, the Baltic, Central America, Bermuda, and the Caribbean. The company offers cruises ranging in length from 1 day to 3 weeks. As of December 31, 2012, it operated 11 ships offering cruises in Alaska, the Bahamas, Bermuda, the Caribbean, Europe, Hawaii, Mexico, New England, Central and South America, North Africa, and Scandinavia. The company was formerly known as NCL Corporation Ltd. and changed its name on January 24, 2013. Norwegian Cruise Line Holdings Ltd. was founded in 1966 and is headquartered in Miami, Florida.
Advisors' Opinion:- [By Rick Munarriz]
Royal Caribbean,�NCL (NYSE: NCL ) , and ship spa services provider Steiner Leisure (NASDAQ: STNR ) all hit new 52-week highs earlier this month. Unlike Carnival (NYSE: CCL ) -- which has been sluggish in light of several mishaps at sea since last year -- everyone seemed to view the negative instances as Carnival-specific events. Now Royal Caribbean's fire may lead folks to question booking on any cruise line in the near future.
- [By Rick Munarriz]
Carnival stock is trading closer to its 52-week low than its high, and the same can't be said of rivals Royal Caribbean (NYSE: RCL ) and NCL (NYSE: NCL ) .�
Best Life Sciences Stocks To Buy For 2014: Rouse Properties Inc (RSE)
Rouse Properties, Inc. (Rouse), incorporated on August 10, 2011, is a real estate investment trust (REIT) company. Rouse is engaged in the operation, development and management of retail rental property. The Company�� portfolio consists of 30 regional malls in 19 states totaling over 21 million square feet of retail and ancillary space. The Company is a regional mall owner in the United State. It manages all of its properties, performing the day-to-day functions, operations, leasing, maintenance, marketing and promotional services. Its malls are anchored by operators across the retail spectrum. The Company�� regional malls include Sikes Senter Mall, Valley Hills Mall, Bayshore Mall and The Boulevard Mall. Its portfolio also includes regional malls that have growth through lease-up, repositioning and redevelopment. Rouse is a wholly owned subsidiary of GGP Limited Partnership (GGPLP), which is majority owned by General Growth Properties, Inc. (GGP). In February 2012, the Company purchased Grand Traverse Mall in Traverse City. In January 2013, the Company acquired the Mall at Turtle Creek and an adjacent shopping center, Turtle Creek Crossing. In July 2013, the Company announced the acquisition of Greenville Mall, in Greenville, North Carolina. In December 2013, the Company acquired Chesterfield Towne Center, in Richmond, Virginia, and the Centre at Salisbury, in Salisbury, Maryland.
The operators across the retail spectrum, including departments stores, such as Macy's, JC Penney, Sears, Dillard's, Walmart and Target; mall shop tenants, such as Hollister, Victoria's Secret, Bath & Body Works, Aeropostale, American Eagle, Children's Place, Gap/Old Navy, Footlocker, Maurices and Forever 21; restaurants ranging from food court, such as Sarku Japan, Panda Express and Chick Fil A; casual chains, such as Chipotle, Panera Bread and Starbucks, and sit down restaurants, including On The Border, Buffalo Wild Wings, Red Robin and multiple Darden concepts.
Advisors' Opinion:- [By Mike Arnold]
Brookfield's public assets include a 21% stake (and potentially more given certain warrants held by Brookfield) in General Growth Properties (GGP), a 51% stake in Brookfield Office Properties (BPO), a 36% stake (again, more if certain warrants are exercised) in Rouse Properties (RSE) and 21% stake in Canary Wharf Group Plc, which is majority owned by Songbird Estates Plc (SBEPF.PK).
No comments:
Post a Comment